Nanosonics Limited

ASX:NAN ISIN:AU000000NAN9

Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets.

Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. In parallel with the commercialisation of this product, Nanosonics is also developing other medical applications and exploring opportunities for its proprietary technology in other industries. 
 
   

View in Other Languages

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 12000

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article

Asian Markets Overview of March 30

🕔3/30/2009 3:00:25 PM 17730

Most Asian markets started the trading session with volatility on Monday after US stocks retreated on Friday. Tokyo and Seoul shares opened flat, and soon proceeded to a negative territory. Today Investors are also awaiting US government to unveil its plan to help the auto industry.

Read Full Article

Nanosonics Limited (ASX:NAN) Commences Production And Commercial First Sales of Trophon EPR

🕔3/30/2009 1:10:45 PM 6052

Nanosonics Limited (ASX:NAN) is pleased to announce that it has commenced production and commercial sale of its breakthrough Trophon(TM) EPR ultrasound probe disinfector system, through distribution partners in New Zealand and Australia.

Read Full Article
###

30,868 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 12) (Last 30 Days: 51) (Since Published: 8575) 

Company Data

    Headquarters
  • Unit 24, 566 Gardeners Road
    Alexandria NSW 2015
    Australia
  • Telephone
  • +61-2-8063-1600 
  • Fax
  • +61-2-9317-5010 
  • Principal Sector
  • Nanotechnology 
  • Principal Industry
  • Medical Products 
  • Homepage
  • http://www.nanosonics.com.au/

More News Results

  • 2024/03/25: Change of Director's Interest Notice*
  • 2024/03/15: Organisational Announcement Chief Technology Officer*
  • 2024/03/14: Ceasing to be a substantial holder for NAN*
  • 2024/03/08: Application for quotation of securities - NAN*
  • 2024/03/05: Change in substantial holding from MUFG*
  • 2024/03/04: Change in substantial holding*
  • 2024/03/04: Change of Director's Interest Notice*
  • 2024/03/04: Change of Director's Interest Notice*
  • 2024/02/29: Change of Director's Interest Notice*
  • 2024/02/29: Change of Director's Interest Notice*
*refer to company website